Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.

Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC.

Circulation. 2013 Aug 27;128(9):944-53. doi: 10.1161/CIRCULATIONAHA.113.003042.

2.

Implantable transvenous cardioverter-defibrillators.

Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D.

Circulation. 1993 Apr;87(4):1152-68.

PMID:
8462144
3.
4.

Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.

Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, Scholten M, Hood M, Kuschyk J, Jones P, Duffy E, Husby M, Stein K, Lambiase PD; EFFORTLESS Investigator Group.

J Am Coll Cardiol. 2017 Aug 15;70(7):830-841. doi: 10.1016/j.jacc.2017.06.040.

5.

Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.

Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, Delnoy PP, van Dessel PF, Driessen AH, de Groot JR, Herrman JP, Jordaens LJ, Kooiman KM, Maass AH, Meine M, Mizusawa Y, Molhoek SG, van Opstal J, Tijssen JG, Wilde AA.

Am Heart J. 2012 May;163(5):753-760.e2. doi: 10.1016/j.ahj.2012.02.012.

6.

Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.

Miyake CY, Webster G, Czosek RJ, Kantoch MJ, Dubin AM, Avasarala K, Atallah J.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):579-87. doi: 10.1161/CIRCEP.113.000170. Epub 2013 May 11.

7.

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.

Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH; ALPHEE Study Investigators.

Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14.

8.

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.

Burke MC, Gold MR, Knight BP, Barr CS, Theuns DA, Boersma LV, Knops RE, Weiss R, Leon AR, Herre JM, Husby M, Stein KM, Lambiase PD.

J Am Coll Cardiol. 2015 Apr 28;65(16):1605-15. doi: 10.1016/j.jacc.2015.02.047.

9.

[Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].

Adragão P, Parreira L, Neves J, Morgado F, Abecassis M, Almeida M, Martins D, Bonhorst D, Seabra-Gomes R.

Rev Port Cardiol. 1996 Mar;15(3):195-206, 179, 181. Portuguese.

PMID:
8634168
10.

Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.

Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA.

Europace. 2013 Mar;15(3):347-54. doi: 10.1093/europace/eus316. Epub 2012 Sep 21.

PMID:
23002195
12.

Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.

Kühlkamp V; InSync 7272 ICD World Wide Investigators.

J Am Coll Cardiol. 2002 Mar 6;39(5):790-7.

13.

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.

Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kääb S, Murgatroyd F, Reeve HL, Carter N, Boersma L; EFFORTLESS Investigators.

Eur Heart J. 2014 Jul 1;35(25):1657-65. doi: 10.1093/eurheartj/ehu112. Epub 2014 Mar 26.

14.

Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.

Glikson M, Lipchenca I, Viskin S, Ballman KV, Trusty JM, Gurevitz OT, Luria DM, Eldar M, Hammill SC, Friedman PA.

J Cardiovasc Electrophysiol. 2004 Jun;15(6):658-64.

PMID:
15175060
15.

Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.

Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto G, Toscano S, Miraglia F, Grammatico A, Santini M.

Eur Heart J. 2002 Sep;23(18):1471-9.

PMID:
12208228
16.

Compatibility of a nonthoracotomy lead system with a biphasic implantable cardioverter-defibrillator. Cadence-Endotak 60-Series IDE investigators.

Porterfield JG, Porterfield LM, Levine JH, Luceri RM, Hsia HH.

Am J Cardiol. 1996 Mar 15;77(8):586-90.

PMID:
8610607
17.

Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.

Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M, Gosau N, Hoffmann B, Hoffmann M, Vettorazzi E, Wilke I, Wegscheider K, Reichenspurner H, Eckardt L, Steven D, Willems S.

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):913-9. doi: 10.1161/CIRCEP.112.973339. Epub 2012 Aug 23.

18.

Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study.

Köbe J, Reinke F, Meyer C, Shin DI, Martens E, Kääb S, Löher A, Amler S, Lichtenberg A, Winter J, Eckardt L.

Heart Rhythm. 2013 Jan;10(1):29-36. doi: 10.1016/j.hrthm.2012.09.126. Epub 2012 Sep 29.

PMID:
23032867
19.

Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.

Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl K, Haffajee CJ; Worldwide Jewel AF Investigators.

J Cardiovasc Electrophysiol. 2001 May;12(5):521-8.

PMID:
11386511

Supplemental Content

Support Center